Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 4, 2011, Pages 483-490

  Gao, Yuan ^a   Zu, Hui ^a   Zhang, Jianjun ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Adefovir dipivoxil; Cocrystal; Dissolution; Saccharin; Stability

Indexed keywords

ADEFOVIR DIPIVOXIL; SACCHARIN;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEN BOND; INFRARED SPECTROSCOPY; MELTING POINT; PH MEASUREMENT; PHYSICAL CHEMISTRY; SOLID STATE; STOICHIOMETRY; X RAY POWDER DIFFRACTION;

ADENINE; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG STABILITY; PHOSPHONIC ACIDS; SACCHARIN; SOLUBILITY;

EID: 79952732175     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01246.x     Document Type: Article

References (25)

1. Dhumal RS et al. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability. J Pharm Pharmacol 2009; 61: 743-751.
2. Bothiraja C et al. Evaluation of molecular pharmaceutical and in-vivo properties of spray-dried isolated andrographolide-PVP. J Pharm Pharmacol 2009; 61: 1465-1472.
3. Andrews GP et al. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharmacol 2010; 62: 1580-1590.
4. Zhang GZ, Zhou D. In Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice. Burlington: Academic Press, 2009.
5. Shan N, Zaworotko MJ. The role of cocrystals in pharmaceutical science. Drug Discov Today 2008; 13: 440-446.
6. Gao Y et al. [Pharmaceutical cocrystals.]. Chem Prog 2010; 22: 829-836 [in Chinese].
7. Fleischman SG et al. Crystal engineering of the composition of pharmaceutical phases: multiple-component crystalline solids involving carbamazepine. Cryst Growth Des 2003; 3: 909-920.
8. Hickey MB et al. Performance comparison of a co-crystal of carbamazepine with marketed product. Eur J Pharm Biopharm 2007; 67: 112-119. (Pubitemid 46991320)
9. Rodriguez-Hornedo N et al. Cocrystals: design, properties, and formation mechanisms. In: Swarbrick J, ed. Encyclopedia of Pharmaceutical Technology. New York: Informa Healthcare USA, Inc, 2007: 615-635.
10. Starrett JE et al. Synthesis, Oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2- (Phosphonomethoxy) ethyl]adenine (PMEA). J Med Chem 1994; 37: 1857-1864.
11. Patrick M et al. Adefovir Dipivoxil for the treatment of hepatitis b e antigen-positive chronic hepatitis B. N Engl J Med 2003; 348: 808-816.
12. Vávrová K et al. Transdermal and dermal delivery of adefovir: effects of pH and permeation enhancers. Eur J Pharm Biopharm 2008; 69: 597-604.
13. Yuan L et al. Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxil. Pharm Res 2000; 17: 1098-1103.
14. Zhang D et al. [New crystalline form and preparation of adefovir dipivoxil]. CN Patent 1303089C, 2007 [in Chinese].
15. Zhang X et al. [Crystalline form of adefovir dipivoxil]. CN Patent 1211391C, 2005 [in Chinese].
16. Murty NA et al. Nucleotide analog compositions. US Patent 006451340B1, 2002.
17. The Committee for Medicinal Products for Human Use. European Medicines Agency, Scientific Discussion [online]. 2009. Available at: http://www.emea. europa.eu/humandocs/Humans/EPAR/hepsera/hepsera.htm (accessed 27 January 2011).
18. Sun WJ et al. Accelerated test's stability comparison of three adefovir dipivoxil products. Chin J New Drug Clin Remedy 2010; 29; 923-927 [in Chinese].
19. Basavoju S et al. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm Res 2008; 25: 530-541. (Pubitemid 351357724)
20. Guguta C et al. Crystal structure of aspartame anhydrate from powder diffraction data. structural aspects of the dehydration process of aspartame. Cryst Growth Des 2006; 6: 2686-2692.
21. Matos MAR et al. Saccharin: a combined experimental and computational thermochemical investigation of a sweetener and sulfonamide. Mol Phys 2005; 103: 221-228. (Pubitemid 41632947)
22. Menegola J et al. Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles. Eur J Pharm Biopharm 2007; 67: 524-530. (Pubitemid 47211896)
23. US Food and Drug Administration. Guidance for Industry: Dissolution Testing of Immediate Release Solid oral Dosage Forms. Rockville: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 1997.
24. Chang Y et al. 9-{2-[Bis(pivaloyloxymethoxy)phosphinylmethoxy] ethyl}adenine dihydrate. Acta Crystallogr Section E 2007; 63: o1014-o1015.
25. Yuan L et al. Degradation kinetics of oxycarbonyloxymethyl prodrugs of phosphonates in solution. Pharm Res 2001; 18: 234-237. (Pubitemid 32592604)